OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.520
-0.050 (-3.18%)
At close: Aug 11, 2026, 4:00 PM EDT
1.600
+0.080 (5.26%)
After-hours: Aug 11, 2026, 4:22 PM EDT

OKYO Pharma Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Income
-2.5-8.5-7.09-15.75-13.28-6.22
Net Income
-8.95-8.95-4.71-16.83-13.27-5.43
Earnings Per Share
-15.24-15.24-7.80-37.05-39.65-23.40
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
20.5920.591.560.834.052.7
Total Debt
00002.220
Net Cash (Debt)
20.5920.591.560.831.832.7
Net Cash Growth
410.44%1219.38%88.78%-54.82%-32.27%-60.58%
Net Cash Per Share
35.0735.072.571.835.3511.66

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-5.94-5.94-1.81-9.49-7.7-5.47
Capital Expenditures
-0.01-0.01-0--0.01-0
Free Cash Flow
-5.94-5.94-1.81-9.49-7.7-5.47
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.